Diffuse Cutaneous Systemic Sclerosis Clinical Trials in Ningbo, Zhejiang
2 recruitingNingbo, Zhejiang, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Diffuse Cutaneous Systemic Sclerosis
Novartis Pharmaceuticals200 enrolled127 locationsNCT06470048
Recruiting
Phase 2
Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis
Diffuse Cutaneous Systemic Sclerosis
Second Affiliated Hospital, School of Medicine, Zhejiang University38 enrolled9 locationsNCT06375005